Advertisement

Topics

Cytomegalovirus Prevention in Critically Ill Patients

20:00 EDT 21 Aug 2017 | JAMA

Approximately 50% to 60% of the North American population is infected with cytomegalovirus (CMV), a DNA herpesvirus that establishes lifelong latency in various cell types. For the vast majority of the population, the virus is maintained in latency through T-cell control although other cell types such as natural killer cells, monocytes, and macrophages also play a role. Thus, for a healthy immunocompetent individual, there is minimal long-term consequence of infection outside of certain settings, such as congenital CMV. In transplantation, including solid organ and hematopoietic stem cell, CMV is the most common opportunistic infection and can be acquired through primary infection from the donor allograft or from reactivation of endogenous latent virus.

Original Article: Cytomegalovirus Prevention in Critically Ill Patients

NEXT ARTICLE

More From BioPortfolio on "Cytomegalovirus Prevention in Critically Ill Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...